FILE PHOTO: A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020.
HONG KONG: Hong Kong has formally approved China’s Sinovac vaccine for emergency use, the city’s health secretary said today, paving the way for its introduction in the global financial hub.
In a statement, Sophia Chan said the vaccine met the “safety, efficacy and quality requirements specified in Hong Kong emergency situations”.
